Lingling Xu

机构：Southern Medical University · ORCID：0000-0003-2731-4758

发表论文 72 篇 · 总被引 1402 次 · h-index 24

代表论文

• Gestational GenX and PFOA exposures induce hepatotoxicity, metabolic pathway, and microbiome shifts in weanling mice (2023 · The Science of The Total Environment · 被引 35)
• CDK5-USP30 signaling pathway regulates MAVS-mediated inflammation via suppressing mitophagy in MPTP/MPP+ PD model (2024 · Ecotoxicology and Environmental Safety · 被引 10)
• Impact of rosuvastatin on metabolic syndrome patients with moderate to severe metabolic associated fatty liver disease without overt diabetes: A randomized clinical trial (2024 · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 被引 8)
• Low rectus femoris mass index is closely associated with diabetic peripheral neuropathy (2023 · Frontiers in Endocrinology · 被引 8)
• MicroRNA-24-3p targeting Top1 in perirenal fat is involved in circulating inflammation and high cardiovascular disease risk in patients with primary aldosteronism (2025 · Journal of Translational Medicine · 被引 7)
• Diminished levels of insulin‐like growth factor‐1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients (2024 · Journal of Diabetes Investigation · 被引 7)